🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07163676
Recruiting Not applicable

Is There a Response of Glaucoma to Baduanjin Exercise in Elders?

NCT07163676 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-05-11
Last updated
2025-09-09

Condition(s) studied

Glaucoma

Investigational drug(s) / intervention(s)

Baduanjin exercise

Baduanjin exercise: group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks.

Study summary

glaucoma is prevalent between elders. Baduanjin exercise is a suitable exercise for elders. elders with glaucoma will divided to group I or group II. each/every group will contain 30 elders. group I will receive baduanjin exercise for 60 minutes every day ((except fridays) for eight weeks. group II will act as waistlist.

Eligibility

Sex
ALL
Min age
65 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * high-tension primary open angle glaucoma (bilateral) * ocular hypertension in both eyes Exclusion Criteria: * cataract * diabetes * cardiac disorders * obesity

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cairo University Giza Dokki Recruiting

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07163676 on ClinicalTrials.gov ↗ ← All trials in Egypt